Bionyra Pharma
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7-11 Boulevard Haussmann, Paris, Île-de-...Website
www.bionyra.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Bionyra Pharma
Bionyra Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bionyra Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Bionyra Pharma recently announced quarterly report
Product Launch: Get notified when Bionyra Pharma launches new products
Website visits: Recent activity has been detected on your website
Bionyra Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bionyra Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Bionyra Pharma
Check out if Bionyra Pharma is spiking on competitors!
Check if Bionyra Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bionyra Pharma has new funding data
Recommended Actions
Reach out to Masked Content who joined Bionyra Pharma as Masked Content
Find 2 more new buyers
Bionyra Pharma financials insights
Gather financial insights about Bionyra Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$165M
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Bionyra Pharma
Bionyra Pharma is a clinical-stage biotechnology company developing next-generation biologic therapies for severe immune-mediated inflammatory diseases. The company focuses on advanced monoclonal and multispecific antibody programs designed to target key immune pathways and provide deeper, longer-lasting disease control. Its pipeline includes thera... Read More
